… novel classes of drugs, most patients develop therapeutic resistance … the Food and Drug Administration (FDA) for use in … discontinued treatment due to xerostomia. Common medications employed to manage xerostomia … 2 MagnetisMM-3 trial results. Nat Med. 2023;29( …

… effective without significant side effects. Developed by the University of South … a lipid-based drug delivery system to treat dry mouth (xerostomia), a common … undergoing radiotherapy and other medical treatments regularly experience dry mouth, which …

… ;2a Trial in Radiation-Induced Xerostomia and … effective in treating rare genetic … FDA for RGT-61159, which is being developed for the potential treatment … Pharmaceuticals, Arbutus Biopharm, Dicerna Pharmaceuticals, Inc., SanegeneBio, Alnylam Pharmaceuticals, …

… response to AAV-GAD treatment.” Dr. Forbes continued, … disease and radiation-induced xerostomia. MeiraGTx uses its … for clinical medicine and pharmaceutical drug development. Hologen builds the … used to increase trial success probabilities substantially …

… complexity of treatments and patient care seen across health systems, pharmacists continue … conditions such as xerostomia (dry mouth), the importance of medication education, and …

… risks in patients suffering from xerostomia (dry mouth). The device, currently … treatment to support their oral health and prevent serious infections from developing … health development over two months to assess how regular Lumoral treatment affects …

… treatments with Actinium, but they did have high rates of xerostomia … distinct aspects of this new drug. Number one is, as … we saw the SPLASH trial and ECLIPSE trial showing positive results … presenting this new modality to treat prostate cancer, and for …

… hormonal imbalances, and certain medications. Treatment of PG mainly includes … betamethasone (Shanghai Schering-Plough Pharmaceutical Co., Ltd., SFDA … experienced only mild xerostomia without any other adverse … use of thalidomide in treating PG, offering a …

… old) receiving sequential bilateral treatment. Meaningful responses have … the Food and Drug Administration (FDA) to discuss a … s disease, radiation-induced xerostomia and AIPL1-associated retinal … , identify additional and develop existing product candidates, …

Hyperhidrosis can be a profoundly impactful condition, often misunderstood by both patients and clinicians. Adam Friedman, MD, FAAD, a dermatologist based in Washington, DC, and a professor and chair of dermatology at the George Washington University …